Links in the following list of references are for citations and abstracts available on PubMed through the National Library of Medicine (NLM). Please see the NLM Disclaimer and Copyright Notice for information regarding copyright status of its site contents.
The significance of immediate coagulation monitoring during the treatment for DIC. WAN, P., YU, M., TONG, H. S., & SU, L. (2015). Medical Journal of Chinese People's Liberation Army, 40(8), 632-637.
Assays of different aspects of haemostasis – what do they measure? Tynngård, N, Lindahl TL, Ramström S. Thromb J. 2015 Feb 5;13:8.
Viscoelastic Blood Coagulation Measurement With Sonoclot Predicts Postoperative Bleeding in Cardiac Surgery After Heparin Reversal. Bischof DB, Ganter MT, Shore-Lesserson L, Hartnack S, Klaghofer R, Graves K, Genoni M, Hofer CK J Cardiothorac Vasc Anesth 2015. Jan;29(3):715-722.
Haemostatic management of cardiac surgical haemorrhage. Besser MW, Ortmann E, Klein AA. Anaesthesia 2015 70(s1), 87-e31.
Novel HIT antibody detection method using Sonoclot® coagulation analyzer. Wanda K, Asada R, Miyashita K, Keneko M, Endo H, Yatomi Y. Thromb Res 2015 Jan;135(1):127-9.
Dabigatran and its reversal with recbinant factor VIIa and prothrombin complex concentrate: a Sonoclot in vitro study. Sølbeck S, Nilsson CU, Ensgtröm M, Ostrowski SR, Johansson PI. Stand J Clin Lab Invest. 2014 Oct;74(7):591-8.
Diagnosis of overt disseminated intravascular coagulation in critically ill adults by Sonoclot coagulation analysis. Wan P, Tong HS, Zhang XQ, Duan PK, Tang YQ, Su L. Int J Hematol. 2014 Aug;100(2):125-31.
Sonoclot signature analysis in patients with liver disease and its correlation with conventional coaglation studies. Saxena P, Bihari C, Rastogi A, Agarwal S, Anand L, Sarin SK. Adv Hematol. 2013:237351.
Sonoclot analysis in children with congenital heart disease. Chardhary V, Chauhan S, Choudhury M, Kiran U, Talwar S, Kapoor PM. Asian Cardiovasc Throac Ann. 2012 Oct;20(5):544-7.
Sonoclot® evaluation of single- and multiple-dose subcutaneous unfractionated heparin therapy in healthy adult dogs. Babski DM, Brainard BM, Ralph AG, Pittman JR, Koenig A. J Vet Intern Med. 2012 May-Jun;26(3):631-8.
Evaluation of the Coagulation Profile Among Oral and Vaginal Combined Hormonal Contraceptive Users Using Sonoclot Coagulation Analyzer. Brandy KR, Meyer RM, Luo X, Rao GH, Datta YH, Divani AA. Clin Appl Thromb Hemost. 2012 Jan 31.
Utility of Sonoclot analysis and tranexamic acid in tetralogy of Fallot patients undergoing intracardiac repair. Aggarwal V, Kapoor PM, Choudhury M, Kiran U, Chowdhury U. Ann Card Anaesth. 2012 Jan-Mar;15(1):26-31.
Standard subcutaneous dosing of unfractionated heparin for venous thromboembolism prophylaxis in surgical ICU patients leads to subtherapeutic factor Xa inhibition. Cheng SS, Nordenholz K, Matero D, Pearlman N, McCarter M, Gajdos C, Hamiel C, Baer A, Luzier E, Tran ZV, Olson T, Queensland K, Lutz R, Wischmeyer P. Intensive Care Med. 2012 Apr;38(4):642-8.
Assessment of heparin anticoagulation by Sonoclot Analyzer in arterial reconstruction surgery. Lee B, Al-Waili N, Butler G, Salom K. Technol Health Care. 2011;19(2):109-14.
Effects on coagulation of balanced (130/0.42) and non-balanced (130/0.4) hydroxyethyl starch or gelatin compared with balanced Ringer's solution: an in vitro study using two different viscoelastic coagulation tests ROTEMTM and SONOCLOTTM. Casutt M, Kristoffy A, Schuepfer G, Spahn DR, Konrad C. Br J Anaesth. 2010 Sep;105(3):273-81.
Monitoring of low molecular weight heparin anticoagulation during haemodialysis with a Sonoclot Analyzer. Schött U, Nilsson LG, Broman M, Engström M. Perfusion. 2010 Jul;25(4):191-6.
Haemostasis monitoring during sequential aortic valve replacement and liver transplantation. Sieders E, De Somer F, Bouchez S, Szegedi L, Van Belleghem Y, Colle I, Troisi R. Acta Gastroenterol Belg. 2010 Jan-Mar;73(1):65-8.
Appropriate dosage of unfraction heparin and low molecular weight heparin in hemodialysis patients. Xiao Q, Sun XF, Zhang D, Ma ZF, Wu MG, Wang H, Chen XM. Zhonghua Yi Xue Za Zhi. 2010 Jan 19;90(3):187-91. [Chinese]
Therapeutic mild hypothermia: effects on coagulopathy and survival in a rat hemorrhagic shock model. Iwamoto S, Takasu A, Sakamoto T. J Trauma. 2010 Mar;68(3):669-75.
In vitro anticoagulation monitoring of low-molecular-weight heparin. Wang JQ, Shi XB, Yang JG, Hu DY. Chin Med J (Engl). 2009 May 20;122(10):1199-202.
Monitoring recombinant factor VIIa treatment: efficacy depends on high levels of fibrinogen in a model of severe dilutional coagulopathy. Ganter MT, Schmuck S, Hamiel CR, Wischmeyer PE, Heule D, Zollinger A, Hofer CK. J Cardiothorac Vasc Anesth. 2008 Oct;22(5):675-80. Epub 2008 Apr 9.
Sonoclot analysis in coronary artery surgery: a comparison between patients with unstable coronary artery disease treated with enoxaparin before surgery and patients with stable coronary artery disease not treated with enoxaparin. Pleym H, Wahba A, Bjella L, Stenseth R. J Cardiothorac Vasc Anesth. 2008 Oct;22(5):670-4. Epub 2008 Mar 24.
Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Ganter MT, Hofer CK. Anesth Analg. 2008 May;106(5):1366-75.
Sonoclot analysis in elderly compared with younger patients undergoing coronary surgery. Pleym H, Wahba A, Bjella L, Stenseth R. Acta Anaesthesiol Scand. 2008 Jan;52(1):28-35.
Aprotinin does not prolong the Sonoclot aprotinin-insensitive activated clotting time. Dong Y, Nuttall GA, Oliver WC Jr, Agarwal S, Ereth MH. J Clin Anesth. 2007 Sep;19(6):424-8.
Thrombin generation assay and viscoelastic coagulation monitors demonstrate differences in the mode of thrombin inhibition between unfractionated heparin and bivalirudin. Tanaka KA, Szlam F, Sun HY, Taketomi T, Levy JH. Anesth Analg. 2007 Oct;105(4):933-9.
Monitoring fondaparinux with the Sonoclot. Nilsson CU, Engström M. Blood Coagul Fibrinolysis. 2007 Oct;18(7):619-22.
Kaolin-based activated coagulation time measured by sonoclot in patients undergoing cardiopulmonary bypass. Ganter MT, Monn A, Tavakoli R, Klaghofer R, Zollinger A, Hofer CK. J Cardiothorac Vasc Anesth. 2007 Aug;21(4):524-8.
Impact of Sonoclot hemostasis analysis after cardiopulmonary bypass on postoperative hemorrhage in cardiac surgery. Yamada T, Katori N, Tanaka KA, Takeda J. J Anesth. 2007;21(2):148-52.
Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparin. Mousa SA, Linhardt R, Francis JL, Amirkhosravi A. Thromb Haemost. 2006 Dec;96(6):816-21.
Impairment of coagulation by commonly used resuscitation fluids in human volunteers. Coats TJ, Brazil E, Heron M, MacCallum PK. Emerg Med J. 2006 Nov;23(11):846-9.
Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot. Ganter MT, Monn A, Tavakoli R, Genoni M, Klaghofer R, Furrer L, Honegger H, Hofer CK. Eur J Cardiothorac Surg. 2006 Aug;30(2):278-84.
Platelet function monitoring with the Sonoclot analyzer after in vitro tirofiban and heparin administration. Tucci MA, Ganter MT, Hamiel CR, Klaghofer R, Zollinger A, Hofer CK. J Thorac Cardiovasc Surg. 2006 Jun;131(6):1314-22.
Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis. Biagini MR, Tozzi A, Marcucci R, Paniccia R, Fedi S, Milani S, Galli A, Ceni E, Capanni M, Manta R, Abbate R, Surrenti C. World J Gastroenterol. 2006 Mar 14;12(10):1607-12.
Effects of heparin, haemodilution and aprotinin on kaolin-based activated clotting time: in vitro comparison of two different point of care devices. Dalbert S, Ganter MT, Furrer L, Klaghofer R, Zollinger A, Hofer CK. Acta Anaesthesiol Scand. 2006 Apr;50(4):461-8.
Reduced erythrocyte deformability and hypercoagulability in idiopathic sudden sensorineural hearing loss. Mannini L, Paniccia R, Cecchi E, Alessandrello Liotta A, Leprini E, Berloco P, Pagnini P, Abbate R, Franco Gensini G, Prisco D. Clin Hemorheol Microcirc. 2005;33(1):47-55.
Monitoring activated clotting time for combined heparin and aprotinin application: an in vitro evaluation of a new aprotinin-insensitive test using SONOCLOT. Ganter MT, Dalbert S, Graves K, Klaghofer R, Zollinger A, Hofer CK. Anesth Analg. 2005 Aug;101(2):308-14.
Intermittent pneumatic foot compression can activate blood fibrinolysis without changes in blood coagulability and platelet activation. Kohro S, Yamakage M, Sato K, Sato JI, Namiki A. Acta Anaesthesiol Scand. 2005 May;49(5):660-4.
Presentation of laboratory and sonoclot variables using principal component analysis: identification of hypo- and hypercoagulation in the HELLP syndrome. Liszka-Hackzell JJ, Schött U. J Clin Monit Comput. 2004 Aug;18(4):247-52.
Pravastatin potentiates the anticoagulant effects of low molecular weight heparin. Zimmer JE, Spillert CR, Puppala S, Zamecki K, Bhatt BA, Arora RR. Thromb Res. 2004;113(6):407-10.
Effects of tirofiban on haemostatic activation in vitro. Tanaka KA, Katori N, Szlam F, Sato N, Kelly AB, Levy JH. Br J Anaesth. 2004 Aug;93(2):263-9.
Sonoclot analysis in cardiac surgery in dialysis-dependent patients. Shibata T, Sasaki Y, Hattori K, Hirai H, Hosono M, Fujii H, Suehiro S. Ann Thorac Surg. 2004 Jan;77(1):220-5.
Celite-activated viscometer Sonoclot can measure the suppressive effect of tranexamic acid on hyperfibrinolysis in cardiac surgery. Kamada Y, Yamakage M, Niiya T, Tsujiguchi N, Chen X, Namiki A. J Anesth. 2001;15(1):17-21.
The influence of induced hypothermia for hemostatic function on temperature-adjusted measurements in rabbits. Shimokawa M, Kitaguchi K, Kawaguchi M, Sakamoto T, Kakimoto M, Furuya H. Anesth Analg. 2003 Apr;96(4):1209-13.
Sonoclot coagulation analysis: new bedside monitoring for determination of the appropriate heparin dose during haemodialysis. Furuhashi M, Ura N, Hasegawa K, Yoshida H, Tsuchihashi K, Miura T, Shimamoto K. Nephrol Dial Transplant. 2002 Aug;17(8):1457-62.
Analysis of the information content in Sonoclot data and reconstruction of coagulation test variables. Liszka-Hackzell JJ, Ekback G. J Med Syst. 2002 Feb;26(1):1-8.
Bleeding in a patient receiving platelet aggregation inhibitors. Waters JH, Anthony DG, Gottlieb A, Sprung J. Anesth Analg. 2001 Oct;93(4):878-82.
Blood coagulation monitoring during liver transplantation: Sonoclot analysis and laboratory tests. Bindi ML, Biancofiore GD, Consani G, Cellai F, Cecconi N, Romanelli A, Filipponi F, Mosca F, Amorese G, Vagelli A. Minerva Anestesiol. 2001 May;67(5):359-69. [Italian].
Aortic valve replacement in a patient with factor XII deficiency: case report. Murakami T, Shibata T, Sasaki Y, Hosono M, Suehiro S, Kinoshita H. J Heart Valve Dis. 2001 May;10(3):377-9.
Sonoclot analysis in healthy children. Pivalizza EG, Pivalizza PJ, Kee S, Gottschalk LI, Szmuk P, Abramson DC. Anesth Analg. 2001 Apr;92(4):904-6.
Sonoclot coagulation analysis of in-vitro haemodilution with resuscitation solutions. Brazil EV, Coats TJ. J R Soc Med. 2000 Oct;93(10):507-10.
Measurement of tissue factor activity in whole blood. Santucci RA, Erlich J, Labriola J, Wilson M, Kao KJ, Kickler TS, Spillert C, Mackman N. Thromb Haemost. 2000 Mar;83(3):445-54.
Sonoclot signature during normal pregnancy. Kjellberg U, Hellgren M. Intensive Care Med. 2000 Feb;26(2):206-11.
In vitro effects of different medium molecular hydroxyethyl starch solutions and lactated Ringer's solution on coagulation using SONOCLOT. Konrad CJ, Markl TJ, Schuepfer GK, Schmeck J, Gerber HR. Anesth Analg. 2000 Feb;90(2):274-9.
Sonoclot coagulation analysis: a study of test variability. Ekbäck G, Carlsson O, Schött U. J Cardiothorac Vasc Anesth. 1999 Aug;13(4):393-7.
The effects of intentional hyperthermia on the Thrombelastograph and the Sonoclot analyser. Pivalizza EG, Koch SM, Mehlhorn U, Berry JM, Bull. Int J Hyperthermia. 1999 May-Jun;15(3):217-23.
The effects of in vitro hemodilution with gelatin, hydroxyethyl starch, and lactated Ringer's solution on markers of coagulation: an analysis using SONOCLOT. Konrad C, Markl T, Schuepfer G, Gerber H, Tschopp M. Anesth Analg. 1999 Mar;88(3):483-8.
Clinical utility of available methods for determining platelet function. McKenzie ME, Gurbel PA, Levine DJ, Serebruany VL. Cardiology. 1999;92(4):240-7.
Evaluation of platelet function by Sonoclot analysis compared with other hemostatic variables in cardiac surgery. Miyashita T, Kuro M. Anesth Analg. 1998 Dec;87(6):1228-33.
Coagulation tests predict bleeding after cardiopulmonary bypass. Nuttall GA, Oliver WC, Ereth MH, Santrach PJ. J Cardiothorac Vasc Anesth. 1997 Dec;11(7):815-23.
Perioperative thromboelastography and sonoclot analysis in morbidly obese patients. Pivalizza EG, Pivalizza PJ, Weavind LM. Can J Anaesth. 1997 Sep;44(9):942-5.
Perioperative hypercoagulability in uremic patients: a viscoelastic study. Pivalizza EG, Abramson DC, Harvey A. J Clin Anesth. 1997 Sep;9(6):442-5.
Template for rapid analysis of the Sonoclot Signature. Lyew MA, Spaulding WC. J Clin Monit. 1997 Jul;13(4):273-7.
Effect of age, gender, and platelet count on Sonoclot coagulation analysis in patients undergoing orthopedic operations. Horlocker TT, Schroeder DR. Mayo Clin Proc. 1997 Mar;72(3):214-9.
Determination of tumor cell procoagulant activity by Sonoclot analysis in whole blood. Amirkhosravi A, Biggerstaff JP, Warnes G, Francis DA, Francis JL. Thromb Res. 1996 Dec 1;84(5):323-32.
Sonoclot analysis. Hett DA, Walker D, Pilkington SN, Smith DC. Br J Anaesth. 1995 Dec;75(6):771-6.
Evaluation of the hemostatic clot formation of newborns by Sonoclot coagulation analyzer. Yang YC, Tsai SK, Ng KO, Keung LK, Hseu SS, Lee TY. Zhonghua Yi Xue Za Zhi (Taipei). 1995 Aug;56(2):115-9.
Perioperative autotransfusion and functional coagulation analysis in total hip replacement. Ekbäck G, Schött U, Axelsson K, Carlberg M. Acta Anaesthesiol Scand. 1995 Apr;39(3):390-5.
Sonoclot coagulation analysis and plasma exchange in a case of meningococcal septicaemia. Schött U, Björsell-Ostling E. Can J Anaesth. 1995 Jan;42(1):64-8.
Use of a coagulation analyzer in managing disseminated intravascular coagulation after midtrimester pregnancy termination. A case report. Wasson AW, Stubblefield PG. J Reprod Med. 1994 Oct;39(10):835-7.
Assessment of hypercoagulability in patients with cancer using the Sonoclot Analyzer and thromboelastography. Francis JL, Francis DA, Gunathilagan GJ. Thromb Res. 1994 May 15;74(4):335-46.
Thromboelastography and Sonoclot analysis in the healthy parturient. Steer PL, Krantz HB. J Clin Anesth. 1993 Sep-Oct;5(5):419-24.
Evaluation of post-cardiopulmonary bypass Sonoclot signatures in patients taking nonsteroidal anti-inflammatory drugs. Stern MP, DeVos-Doyle K, Viguera MG, Lajos TZ. J Cardiothorac Anesth. 1989 Dec;3(6):730-3.
Comparison of viscoelastic measures of coagulation after cardiopulmonary bypass. Tuman KJ, Spiess BD, McCarthy RJ, Ivankovich AD. Anesth Analg. 1989 Jul;69(1):69-75.
Comparison of Thromboelastograph and Sonoclot coagulation analyzer for assessing coagulation status during orthotopic liver transplantation. Chapin JW, Becker GL, Hulbert BJ, Newland MC, Cuka DJ, Wood RP, Shaw BW Jr. Transplant Proc. 1989 Jun;21(3):3539.
Assessment of neonatal platelet function using a viscoelastic technique. Blifeld C, Courtney JT, Gross JR. Ann Clin Lab Sci. 1986 Sep-Oct;16(5):373-9.
Evaluation of a new dynamic viscometer for measuring the viscosity of whole blood and plasma. Chandler WL, Schmer G. Clin Chem. 1986 Mar;32(3):505-7.
Application of mechanical impedance measurements to the study of dysfibrinogens. Schreiber WE, Schmer G. J Lab Clin Med. 1984 Oct;104(4):494-500.
Viscoelastic measurement of clot formation: a new test of platelet function. Saleem A, Blifeld C, Saleh SA, Yawn DH, Mace ML, Schwartz M, Crawford ES. Ann Clin Lab Sci. 1983 Mar-Apr;13(2):115-24.
Detection of hypercoagulability by the measurement of the dynamic loss modulus of clotting blood. Sugiura K, Ikeda Y, Ono F, Watanabe K, Ando Y. Thromb Res. 1982 Jul 15;27(2):161-6.